Baqsimi 3MG spray 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FATQC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,259
Award facts
- Contract value 100% obligated
- $13,258.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,258.57 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 9, 2026, for BAQSIMI 3MG Spray in a two-pack quantity. The contract is non-competitive with no set-aside designation and has an ultimate completion date of February 6, 2026. Performance will be executed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA IDC encompasses a comprehensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for BAQSIMI, an emergency glucagon treatment used for severe hypoglycemia, reflects the company's continued role in fulfilling essential pharmaceutical supply needs for the Department of Defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26FATQC?
SPE2DR26FATQC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FATQC worth?
The government has obligated $13,259 on SPE2DR26FATQC.
Is contract SPE2DR26FATQC an order under another contract?
Yes. SPE2DR26FATQC is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FATQC competed?
The extent of competition for SPE2DR26FATQC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award